Jong-In Park

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Venues

Oncogene

International journal of molecular sciences

NPJ precision oncology

Science signaling

Medical College of Wisconsin

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medical College of Wisconsin Apr 01 2006

United States

Professor :: Biochemistry

Publications

Wenjing Chen, Sophie Dream, Pui-Yin Leung, Pui-Kei Wu, Stuart Wong, Jong-In Park
Selpercatinib combination with the mitochondria-targeted antioxidant MitoQ effectively suppresses RET-mutant thyroid cancer. NPJ precision oncology 8 (1) (2024)
Wenjing Chen, Sophie Dream, Pui-Yin Leung, Pui-Kei Wu, Stuart Wong, Jong-In Park
Selpercatinib combination with the mitochondria-targeted antioxidant MitoQ effectively suppresses RET-mutant thyroid cancer. NPJ precision oncology 8 (1) (2024)
Wenjing Chen, Young Shin Song, Han Sai Lee, Chien-Wei Lin, Junguee Lee, Yea Eun Kang, Seon-Kyu Kim, Seon-Young Kim, Young Joo Park, Jong-In Park
Estrogen-related receptor alpha promotes thyroid tumor cell survival via a tumor subtype-specific regulation of target gene networks. Oncogene (2024)
Wenjing Chen, Sophie Dream, Pui-Yin Leung, Pui-Kei Wu, Stuart Wong, Jong-In Park
Selpercatinib combination with the mitochondria-targeted antioxidant MitoQ effectively suppresses RET-mutant thyroid cancer. NPJ precision oncology 8 (1) (2024)
Wenjing Chen, Young Shin Song, Han Sai Lee, Chien-Wei Lin, Junguee Lee, Yea Eun Kang, Seon-Kyu Kim, Seon-Young Kim, Young Joo Park, Jong-In Park
Estrogen-related receptor alpha promotes thyroid tumor cell survival via a tumor subtype-specific regulation of target gene networks. Oncogene 43 (31) (2024)
Wenjing Chen, Young Shin Song, Han Sai Lee, Chien-Wei Lin, Junguee Lee, Yea Eun Kang, Seon-Kyu Kim, Seon-Young Kim, Young Joo Park, Jong-In Park
Estrogen-related receptor alpha promotes thyroid tumor cell survival via a tumor subtype-specific regulation of target gene networks. Oncogene 43 (31) (2024)
Wenjing Chen, Young Shin Song, Han Sai Lee, Chien-Wei Lin, Junguee Lee, Yea Eun Kang, Seon-Kyu Kim, Seon-Young Kim, Young Joo Park, Jong-In Park
Estrogen-related receptor alpha promotes thyroid tumor cell survival via a tumor subtype-specific regulation of target gene networks. Oncogene 43 (31) (2024)
Wenjing Chen, Young Shin Song, Han Sai Lee, Chien-Wei Lin, Junguee Lee, Yea Eun Kang, Seon-Kyu Kim, Seon-Young Kim, Young Joo Park, Jong-In Park
Estrogen-related receptor alpha promotes thyroid tumor cell survival via a tumor subtype-specific regulation of target gene networks. Oncogene 43 (31) (2024)
Wenjing Chen, Sophie Dream, Pui-Yin Leung, Pui-Kei Wu, Stuart Wong, Jong-In Park
Selpercatinib combination with the mitochondria-targeted antioxidant MitoQ effectively suppresses RET-mutant thyroid cancer. NPJ precision oncology 8 (1) (2024)
Wenjing Chen, Jong-In Park
Tumor Cell Resistance to the Inhibition of BRAF and MEK1/2. International journal of molecular sciences 24 (19) (2023)
Jong-In Park
MAPK-ERK Pathway. International journal of molecular sciences 24 (11) (2023)
Seung-Keun Hong, Dmytro Starenki, Oleta T Johnson, Jason E Gestwicki, Jong-In Park
Analogs of the Heat Shock Protein 70 Inhibitor MKT-077 Suppress Medullary Thyroid Carcinoma Cells. International journal of molecular sciences 23 (3) (2022)
Andrew E Becker, Pui Kei Wu, Jong-In Park
eIF5A-Independent Role of DHPS in p21 CIP1 and Cell Fate Regulation. International journal of molecular sciences 22 (24) (2021)
Pui Kei Wu, Seung-Keun Hong, Wenjing Chen, Andrew E Becker, Rebekah L Gundry, Chien-Wei Lin, Hao Shao, Jason E Gestwicki, Jong-In Park
Mortalin (HSPA9) facilitates BRAF-mutant tumor cell survival by suppressing ANT3-mediated mitochondrial membrane permeability. Science signaling 13 (622) (2020)
Pui Kei Wu, Andrew Becker, Jong-In Park
Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway. International journal of molecular sciences 21 (15) (2020)
Pui-Kei Wu, Seung-Keun Hong, Dmytro Starenki, Kiyoko Oshima, Hao Shao, Jason E Gestwicki, Susan Tsai, Jong-In Park
Mortalin/HSPA9 targeting selectively induces KRAS tumor cell death by perturbing mitochondrial membrane permeability. Oncogene 39 (21) (2020)
Dmytro Starenki, Nadiya Sosonkina, Seung-Keun Hong, Ricardo V Lloyd, Jong-In Park
Mortalin (GRP75/HSPA9) Promotes Survival and Proliferation of Thyroid Carcinoma Cells. International journal of molecular sciences 20 (9) (2019)

Jong-In Park.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jong-In Park